GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Scancell Holdings SCLP.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

81.00p

-3.57%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2026

Revenue

—

FY2017FY2026

Net income

−£17.9m

FY2017FY2026

Free cash flow

−£10.7m

FY2017FY2026

Shareholders' equity

−£19.4m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue—£4.7m—£5.3m——————
Gross profit−£672,000£3.6m−£966,000£4.7m−£740,000−£249,000−£43,000−£21,060−£27,612−£32,581
Research and development£12.0m£14.7m£12.9m£11.6m£9.5m£6.4m£4.7m£4.2m£2.9m£2.8m
Operating income−£17.4m−£15.0m−£18.3m−£11.9m−£14.3m−£9.8m−£6.8m−£6.7m−£4.9m−£4.5m
Net income−£17.9m−£12.3m−£5.9m−£11.9m−£2.1m−£15.5m−£5.5m−£5.6m−£4.2m−£3.5m
Diluted earnings per share-0.17-0.10-0.06-0.15-0.03-0.18-0.10-0.12-0.03-0.04

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets£10.4m£23.1m£23.6m£30.3m£49.1m£8.8m£10.5m£10.5m£14.6m£7.0m
Cash and short-term investments£5.3m£16.9m£14.8m£19.9m£28.7m£41.1m£4.6m£4.6m£10.3m£2.7m
Total liabilities£29.8m£26.9m£27.1m£36.5m£29.6m£1.2m£1.2m£1.2m£696,090£531,879
Debt£17.1m£16.3m£19.9m£21.1m£18.9m£15.4m£129,000———
Shareholders' equity−£19.4m−£3.8m−£3.5m−£6.2m£18.1m£19.5m£9.3m£9.3m£13.9m£6.5m
Shares outstanding104m120m93m82m82m85m54m46m162m101m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−£10.6m−£6.1m−£15.7m−£8.1m−£7.8m−£7.8m−£7.0m−£7.0m−£4.1m−£3.8m
Capital spending−£94,000−£14,000−£177,000−£203,000−£744,000−£27,000−£2,664−£2,664−£11,413−£61,079
Free cash flow−£10.7m−£6.1m−£15.8m−£8.3m−£8.5m−£7.8m−£7.0m−£7.0m−£4.1m−£3.9m

Latest quarters

By quarter end

Apr 2026Oct 2025Apr 2025Oct 2024Apr 2024Oct 2023Apr 2023Oct 2022
Revenue——£4.7m———£5.3m—
Gross profit−£295,000−£377,000£4.1m−£479,000−£532,000−£434,000£4.3m−£458,000
Operating income−£8.5m−£8.9m−£4.5m−£10.5m−£10.1m−£8.1m−£4.7m−£7.2m
Net income−£12.2m−£5.7m£231,000−£12.5m−£3.3m−£2.5m−£8.8m−£3.2m
Diluted earnings per share-0.12-0.050.00-0.13-0.04-0.03-0.11-0.04
Cash from operations−£3.0m−£7.0m−£1.0m−£4.0m−£9.0m−£6.0m−£4.0m−£4.0m
Total assets£10.4m£15.4m£23.1m£16.6m£23.6m£22.3m£30.3m£44.7m
Cash and short-term investments£5.3m£8.6m£16.9m£9.1m£14.8m£13.1m£19.9m£35.6m
Debt£17.0m£16.2m£16.5m£15.7m£19.4m£21.1m£18.8m£8.6m
Shareholders' equity−£19.4m−£8.4m−£3.8m−£15.5m−£3.5m−£11.8m−£6.2m£22.7m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income13.5%12.3%19.1%
Net income14.5%3.0%21.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-4.9-9.7-17.1-7.2-97.7-11.0-13.8-5.8-34.5-35.5
Price to sales—25.2—16.3——————

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-for-1 split · 26 Jul 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.